Table 2 Comparison of adverse cardiovascular events between the two groups, n (%)
Group | Malignant arrhythmia | Severe heart failure | New myocardial infarction | Total |
|---|---|---|---|---|
Control group | 6 (6.87) | 14 (16.09) | 7 (8.05) | 27 (31.03) |
Active group | 5 (5.75) | 3 (3.45) | 5 (5.74) | 13 (14.94) |
Χ2 | 6.363 | |||
P | 0.012 |